)
)
Building the Lab of the Future - Connecting AI, Digitalisation and Automation for Closed-Loop Drug Discovery
- A Moment of Choice: Takeda’s Lab of Tomorrow reflects a belief that research cannot be incrementally improved; it must be re-imagined. AI, digitalization, and automation are no longer optional tools; they are the foundation of how modern science must operate.
- The Prize: The goal is not efficiency, but impact: fewer and faster DMTA cycles, higher probability of technical and regulatory success, and the ability to bring truly differentiated medicines to patients sooner.
- What Real Transformation Demands: This work succeeds only with full commitment. No pilots that never scale. No AI layered onto legacy workflows. No tolerance for fragmented data. We aim to transform research into a new way of working.
- From Vision to Reality: We will share tangible proof points, including AI driving decisions in live programs, lab data flowing digitally through our SAIL partnership with TetraScience, and automated, integrated Tier 1 assay platforms operating as core scientific infrastructure.
- The Call to Action: We will close by asking a simple question: if not now, when? The next three years will define whether research organizations lead this transformation - or are defined by it.
